Actively Recruiting
Real-World Study of Patients With Type 1 Diabetes Treated With Teplizumab as Part of Managed Access Programs (MAPs)
Led by Sanofi · Updated on 2026-04-17
60
Participants Needed
4
Research Sites
37 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study is a multi-country, multi-center retrospective observational cohort study based on secondary data collected via chart review, with the aim of describing patient characteristics (including relevant comorbidities), monitoring and treatment practices related to Type 1 diabetes mellitus (T1D) progression, and time to T1D progression in participants who received teplizumab as part of Managed Access Programs (MAPs). This study design was chosen in order to gain rapid insight into the current use of teplizumab in clinical practice and the characteristics of patients who received the treatment.
CONDITIONS
Official Title
Real-World Study of Patients With Type 1 Diabetes Treated With Teplizumab as Part of Managed Access Programs (MAPs)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patient provided written or electronic informed consent or assent (if under 18) according to local rules before any study activity
- Patient received at least 1 day of teplizumab treatment as part of Managed Access Programs (MAPs)
You will not qualify if you...
- Participation in an interventional clinical study on the index date, defined as starting the product or procedure under investigation that deviates from standard clinical practice
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 4 locations
1
Investigational Site Number: 3800003
Palermo, Italy, 90127
Actively Recruiting
2
Investigational Site Number: 7240001
Madrid, Spain, 28034
Actively Recruiting
3
Investigational Site Number: 7240002
Madrid, Spain, 28046
Actively Recruiting
4
Investigational Site Number: 8260002
London, United Kingdom, E1 1BB
Actively Recruiting
Research Team
T
Trial Transparency email recommended (Toll free for US & Canada)
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here